Top Healthcare Stocks List for 2022
New drugs and devices change healthcare with a rapidity seldom seen in history. Top healthcare stocks involve various sectors of the vast healthcare industry. For example, it ranges from pharmaceuticals to facilities to products improving the lives of patients worldwide.
The Top Healthcare Stocks for 2022
No. 4 AbbVie (NYSE: ABBV)
Global pharmaceutical company AbbVie was founded in 2013 when it was spun off from Abbott Laboratories. In 2021, this top healthcare stock generated revenue of $56.2 billion, with net income of $11.54 billion.
AbbVie owns Allergan, whose best-known product is Botox®. While this neurotoxin treats a variety of conditions, it is virtually synonymous with anti-aging injections. The world’s best-selling drug, Humira®, used to treat several forms of arthritis and Crohn’s disease, is an AbbVie product. However, Humira will lose patent exclusivity in the U.S. next year, and that is its largest market.
Other top AbbVie medications and products include:
- Androgel®
- Armour® Thyroid
- CoolSculpting®
- Estrace® cream
- Lexapro®
- Juvederm®
- Kybella®
- Synthroid®
In the past, AbbVie manufactured and distributed Vicodin®, but the company no longer manufactures or distributes any opioids.
In October 2021, the FDA approved VUITY, the first and only eyedrop to treat presbyopia, or age-related blurry near vision. Presbyopia is a common eye issue, with the majority of those age 40 and up affected eventually. This once-daily prescription treatment should prove a game-changer for a large segment of the population. AbbVie vice chairman and president Michael Severino, M.D. said, “We believe [VUITY] will change the way people and their eye doctors approach presbyopia.”
No. 3 Eli Lilly and Company (NYSE: LLY)
Headquartered in Indianapolis, Indiana, Eli Lilly and Company has been in existence since 1876. Its namesake, Colonel Eli Lilly, was a Civil War veteran. In that time, this top healthcare stock has developed more than 100 medications, including household names and those that changed the world. These include…
- Cialis® (tadalafil)
- Cymbalta® (duloxetine delayed-release capsules)
- Effient® (prasugrel)
- Evista® (raloxifene hydrochloride)
- Prozac® (fluoxetine)
In 1923, Lilly developed the first commercially produced insulin. Now, let’s fast forward to today’s LLY. In February, Lilly announced an agreement with the U.S. government. It will supply up to 600,000 doses of its investigational drug bebtelovimab for at least $720 million. The drug neutralizes the omicron variant of COVID-19, as per pseudovirus and authentic virus data.
On May 13, 2022, the FDA approved Lilly’s Mounjaro™ injection. This is the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type two diabetes. The drug has another benefit, although it was not approved for this purpose, significant weight loss.
In its pipeline, Lilly has SURMOUNT-1 (tirzepatide), a drug designed for weight loss. In clinical trials, patients taking SURMOUNT-1 lost up to 22.5% of their body weight compared to those taking a placebo.
On April 28, Lilly announced its first-quarter 2022 financial results. Revenue growth increased by 15%, with volume growth of 20%. Revenue from COVID-19 antibodies grew by $660 million. Excluding that revenue, revenue grew by 10%. Chairman and CEO David A. Ricks said, “With the depth of our pipeline, and growth of our medicines in the market, we are well-positioned to help address health challenges in areas of significant unmet medical need, such as obesity, Alzheimer’s disease and cancer.”
Keep Reading This Article and Find Out the Top 2 Healthcare Stocks to Buy Now
Enter your email below to read the reveal the top two healthcare stocks.
You’ll also be opted in to receive our free daily e-letter, Investment U, where you’ll find expert investment insight, analysis and stock picks for all the best investment opportunities.
Nunc ut lorem quis urna auctor ornare quis in sem. Donec sodales viverra ante, et scelerisque libero iaculis sit amet. Phasellus fermentum vitae tellus quis suscipit. Ut bibendum aliquet odio, a venenatis augue fermentum at. Nunc fringilla dui lorem, congue blandit ex egestas in. Vestibulum dapibus orci ut felis consequat euismod. Sed pretium, risus vel blandit porttitor, diam diam sodales dui, in lobortis lorem ex vitae est. Nullam ac venenatis massa. Integer blandit, diam et fringilla semper, nulla dui suscipit urna, eget hendrerit quam ex rutrum tellus. Nam imperdiet, nibh nec mollis vulputate, felis ante posuere leo, at ultrices nulla neque vitae mi.Nunc ut lorem quis urna auctor ornare quis in sem. Donec sodales viverra ante, et scelerisque libero iaculis sit amet. Phasellus fermentum vitae tellus quis suscipit. Ut bibendum aliquet odio, a venenatis augue fermentum at. Nunc fringilla dui lorem, congue blandit ex egestas in. Vestibulum dapibus orci ut felis consequat euismod. Sed pretium, risus vel blandit porttitor, diam diam sodales dui, in lobortis lorem ex vitae est. Nullam ac venenatis massa. Integer blandit, diam et fringilla semper, nulla dui suscipit urna, eget hendrerit quam ex rutrum tellus. Nam imperdiet, nibh nec mollis vulputate, felis ante posuere leo, at ultrices nulla neque vitae mi.
Integer blandit, diam et fringilla semper, nulla dui suscipit urna, eget hendrerit quam ex rutrum tellus. Nam imperdiet, nibh nec mollis vulputate, felis ante posuere leo, at ultrices nulla neque vitae mi.Nunc ut lorem quis urna auctor ornare quis in sem. Donec sodales viverra ante, et scelerisque libero iaculis sit amet. Phasellus fermentum vitae tellus quis suscipit. Ut bibendum aliquet odio, a venenatis augue fermentum at. Nunc fringilla dui lorem, congue blandit ex egestas in. Vestibulum dapibus orci ut felis consequat euismod. Sed pretium, risus vel blandit porttitor, diam diam sodales dui, in lobortis lorem ex vitae est. Nullam ac venenatis massa. Integer blandit, diam et fringilla semper, nulla dui suscipit urna, eget hendrerit quam ex rutrum tellus. Nam imperdiet, nibh nec mollis vulputate, felis ante posuere leo, at ultrices nulla neque vitae mi.
Top Healthcare Stocks Considerations
Global demographic trends affect top healthcare stocks. These include aging populations, diabetes and obesity epidemics, as well as patients with chronic diseases living longer. At 19.7%, healthcare spending accounts for nearly one-fifth of the U.S. Gross Domestic Product. While the stock market experiences vicissitudes, which is part of investing, the healthcare segment should remain strong in the long term.
